Form 4: Prothena Corp Public Ltd Co: Chief Accounting Officer Acquires 70,000 Stock Options

Karin L. Walker, Chief Accounting Officer of Prothena Corp Public Ltd Co, reports the acquisition of 70,000 stock options exercisable at $14.95, vesting over four years.

Summary

• Karin L. Walker, the Chief Accounting Officer of Prothena Corp Public Ltd Co, filed a Form 4 on March 7, 2025.
• The form reports a transaction that occurred on March 5, 2025, where Ms. Walker acquired 70,000 stock options.
• These options have an exercise price of $14.95.
• The options vest over a period of four years, starting with 25% vesting on March 5, 2026, and the remainder vesting monthly thereafter, contingent upon continued employment.
• The options expire on March 5, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction (stock option grant) for a key officer, indicating standard compensation practices.

Positives

• The acquisition of stock options by a key officer can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a long-term incentive plan for the Chief Accounting Officer, aligning her interests with the company's performance over the next four years.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel. The vesting schedule is typical for such grants.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded biotechnology companies.
• Vesting schedules of four years with a one-year cliff (25% after one year) followed by monthly vesting are common.
• The exercise price is typically set at or above the market price of the stock on the grant date.

Stakeholder Impact

• The stock option grant aligns the interests of the Chief Accounting Officer with those of the shareholders, incentivizing her to contribute to the company's long-term success.

Key Dates